September 15, 2020
Virtual Events    Webinars      Whitepapers      OnDemand Learning     Podcasts

1. Eli Lilly arthritis drug shortened recovery time for COVID-19 patients when combined with remdesivir Full story

2. 'We're not finished with remdesivir': Gilead CEO says trials underway for inhaled version, outpatient IV version Full story

3. Inspira Health opens 2 retail pharmacies Full story

4. Join us at Becker's first ever Pharmacy Virtual Forum - click here to register!

5. 8 considerations to take when preparing for COVID-19 vaccine distribution Full story

6. Gilead expands oncology portfolio, acquires Immunomedics for $21B Full story

7. Data analytics + hospital pharmacy = cash. Attend this pharma-focused virtual discussion to learn how big data can help hospitals survive the economic downturn.

8. World sees record case increase; judge overturns Pennsylvania's virus restrictions — 6 COVID-19 updates Full story

9. Pfizer to know if COVID-19 vaccine works by end of October, CEO says Full story

10. NIH testing blood thinners as COVID-19 treatment Full story

11. What you don't know about specialty pharmacy may be hampering your financial performance and patient care. Click here to learn how to capture those benefits.

12. Merck invests $1B in Seattle Genetics to develop cancer therapy Full story

13. Daily COVID-19 stats, state-by-state:

How necessity and technology are transforming the patient experience

Identifying Dark Green Dollars During Challenging Times: How hospital CFOs track and influence revenue

What can your organization do to manage high-cost, innovative therapies now and in the future?

Companies to Know
Thank you to our key sponsors


Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

View our profile on LinkedIn Follow us on Twitter Like us on Facebook Check our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication